Jensen NF - Search Results

1

TIMP-1 increases expression and phosphorylation of proteins associated with drug resistance in breast cancer cells.

Hekmat O, Munk S, Fogh L, Yadav R, Francavilla C, Horn H, Würtz SØ, Schrohl AS, Damsgaard B, Rømer MU, Belling KC, Jensen NF, Gromova I, Bekker-Jensen DB, Moreira JM, Jensen LJ, Gupta R, Lademann U, Brünner N, Olsen JV, Stenvang J. Hekmat O, et al. Among authors: jensen nf. J Proteome Res. 2013 Sep 6;12(9):4136-51. doi: 10.1021/pr400457u. Epub 2013 Aug 21. J Proteome Res. 2013. PMID: 23909892

2

Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.

Jensen NF, Stenvang J, Beck MK, Hanáková B, Belling KC, Do KN, Viuff B, Nygård SB, Gupta R, Rasmussen MH, Tarpgaard LS, Hansen TP, Budinská E, Pfeiffer P, Bosman F, Tejpar S, Roth A, Delorenzi M, Andersen CL, Rømer MU, Brünner N, Moreira JM. Jensen NF, et al. Mol Oncol. 2015 Jun;9(6):1169-85. doi: 10.1016/j.molonc.2015.02.008. Epub 2015 Feb 24. Mol Oncol. 2015. PMID: 25759163 Free PMC article.

3

TOP1 gene copy numbers in colorectal cancer samples and cell lines and their association to in vitro drug sensitivity.

Rømer MU, Jensen NF, Nielsen SL, Müller S, Nielsen KV, Nielsen HJ, Brünner N. Rømer MU, et al. Among authors: jensen nf. Scand J Gastroenterol. 2012 Jan;47(1):68-79. doi: 10.3109/00365521.2011.638393. Scand J Gastroenterol. 2012. PMID: 22171973

4

Predictive biomarkers with potential of converting conventional chemotherapy to targeted therapy in patients with metastatic colorectal cancer.

Jensen NF, Smith DH, Nygård SB, Rømer MU, Nielsen KV, Brünner N. Jensen NF, et al. Scand J Gastroenterol. 2012 Mar;47(3):340-55. doi: 10.3109/00365521.2012.640835. Epub 2011 Dec 19. Scand J Gastroenterol. 2012. PMID: 22181013 Review.

5

The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells.

Pedraz-Cuesta E, Christensen S, Jensen AA, Jensen NF, Bunch L, Romer MU, Brünner N, Stenvang J, Pedersen SF. Pedraz-Cuesta E, et al. Among authors: jensen nf. BMC Cancer. 2015 May 16;15:411. doi: 10.1186/s12885-015-1405-8. BMC Cancer. 2015. PMID: 25981639 Free PMC article.

6

The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer.

Lin X, Stenvang J, Rasmussen MH, Zhu S, Jensen NF, Tarpgaard LS, Yang G, Belling K, Andersen CL, Li J, Bolund L, Brünner N. Lin X, et al. Among authors: jensen nf. BMC Genomics. 2015 May 22;16(1):404. doi: 10.1186/s12864-015-1552-y. BMC Genomics. 2015. PMID: 25997618 Free PMC article.

7

Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.

Jensen NF, Agama K, Roy A, Smith DH, Pfister TD, Rømer MU, Zhang HL, Doroshow JH, Knudsen BR, Stenvang J, Brünner N, Pommier Y. Jensen NF, et al. J Exp Clin Cancer Res. 2016 Mar 31;35:56. doi: 10.1186/s13046-016-0335-x. J Exp Clin Cancer Res. 2016. PMID: 27029323 Free PMC article.

8

A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification.

Tarpgaard LS, Qvortrup C, Nygård SB, Nielsen SL, Andersen DR, Jensen NF, Stenvang J, Detlefsen S, Brünner N, Pfeiffer P. Tarpgaard LS, et al. Among authors: jensen nf. BMC Cancer. 2016 Feb 11;16:91. doi: 10.1186/s12885-016-2124-5. BMC Cancer. 2016. PMID: 26867764 Free PMC article. Clinical Trial.

9

Underpinning the repurposing of anthracyclines towards colorectal cancer: assessment of topoisomerase II alpha gene copy number alterations in colorectal cancer.

Nygård SB, Christensen IJ, Smith DH, Nielsen SL, Jensen NF, Nielsen HJ, Vainer B, Brünner N. Nygård SB, et al. Among authors: jensen nf. Scand J Gastroenterol. 2013 Dec;48(12):1436-43. doi: 10.3109/00365521.2013.848230. Epub 2013 Oct 21. Scand J Gastroenterol. 2013. PMID: 24138107

10

The therapeutic potential of microRNAs in cancer.

Thorsen SB, Obad S, Jensen NF, Stenvang J, Kauppinen S. Thorsen SB, et al. Among authors: jensen nf. Cancer J. 2012 May-Jun;18(3):275-84. doi: 10.1097/PPO.0b013e318258b5d6. Cancer J. 2012. PMID: 22647365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page